|
TMEM5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38319999898329E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61040000223878E-08 |
| Normal-vs-Stage2 |
1.164330E-02 |
| Normal-vs-Stage3 |
3.87279996960643E-09 |
| Normal-vs-Stage4 |
1.11090026067018E-10 |
| Stage1-vs-Stage2 |
1.646240E-01 |
| Stage1-vs-Stage3 |
1.634160E-01 |
| Stage1-vs-Stage4 |
1.146480E-02 |
| Stage2-vs-Stage3 |
4.270100E-02 |
| Stage2-vs-Stage4 |
8.859600E-03 |
| Stage3-vs-Stage4 |
2.911200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18750009825419E-10 |
| Normal-vs-AfricanAmerican |
5.87029999999933E-05 |
| Normal-vs-Asian |
1.64800999999937E-05 |
| Caucasian-vs-AfricanAmerican |
8.883000E-01 |
| Caucasian-vs-Asian |
3.414800E-01 |
| AfricanAmerican-vs-Asian |
5.760600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.4245053721379E-11 |
| Normal-vs-Female |
2.35179999918955E-08 |
| Male-vs-Female |
1.891600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.20579999821169E-08 |
| Normal-vs-Age(41-60Yrs) |
7.30870000076322E-08 |
| Normal-vs-Age(61-80Yrs) |
1.63319999968436E-07 |
| Normal-vs-Age(81-100Yrs) |
2.951600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.807200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.656800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.959400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.110600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.023600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.509800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.679980E-03 |
| Classical-VS-Follicular |
8.918400E-02 |
| Classical-VS-Other |
1.996780E-01 |
| Classical-VS-Normal |
2.49370002425309E-09 |
| Tall-VS-Follicular |
3.566000E-04 |
| Tall-VS-Other |
9.734600E-01 |
| Tall-VS-Normal |
1.72399983178195E-10 |
| Follicular-VS-Other |
1.808750E-01 |
| Follicular-VS-Normal |
5.258000E-03 |
| Other-VS-Normal |
3.646000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45000000006945E-07 |
| Normal-vs-N1 |
3.46509487769708E-11 |
| N0-vs-N1 |
3.680200E-03 |
|
|
